Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
When would you consider upfront eculizumab for sickle cell hyperhemolysis?
How long after eculizumab infusion would you wait before giving blood transfusions?
Related Questions
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Is there any indication for hydroxyurea in patients with sickle cell trait?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
How do you manage mild Type 1 von Willebrand disease undergoing wisdom teeth removal?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?